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Cancer survival differences between South
Asians and non-South Asians of England in
1986–2004, accounting for age at diagnosis
and deprivation
C Maringe*,1, R Li1, P Mangtani1, M P Coleman1 and B Rachet1
1Faculty of Epidemiology and population Health, London school of Hygiene and Tropical Medicine, Keppel Street, London WC1E
7HT, UK
Background: South Asian migrants show lower cancer incidence than their host population in England for most major cancers. We
seek to study the ethnic differences in survival from cancer.
Methods: We described and modelled the effect of ethnicity, time, age and deprivation on survival for the five most incident
cancers in each sex in South Asians in England between 1986 and 2004 using national cancer registry data. South Asian ethnicity
was flagged using the validated name-recognition algorithm SANGRA (South Asian Names and Group Recognition Algorithm).
Results:We observed survival advantage in South Asians in earlier periods. This ethnic gap either remained constant or narrowed
over time. By 2004, age-standardised net survival was comparable for all cancers except three in men, where South Asians had
higher survival 5 years after diagnosis: colorectal (58.9% vs 53.6%), liver (15.0% vs 9.4%) and lung (15.9% vs 9.3%). Compared with
non-South Asians, South Asians experienced a slower increase in breast and prostate cancer survival, both cancers associated with
either a screening programme or an early diagnosis test. We did not find differential patterns in survival by deprivation between
both ethnicities.
Conclusions: Considering recent survival trends, appropriate action is required to avoid deficits in cancer survival among South
Asians in the near future.
People of Indian, Pakistani and Bangladeshi origin (South Asian)
comprise the biggest minority ethnic group in the UK, constituting
4% of the total UK population, or half of all the non-European
population in the UK (Office for National Statistics, 2003). South
Asians mostly migrated to the UK in the 1950s and 1960s. The
literature of cancer patterns in migrant populations refer to them
as either South Asians or South Asian migrants, often without
distinguishing between the first, second and the third generations.
Patterns of cancer incidence, mortality and survival in South
Asians in the UK have been shown to differ from the host
population (Moles et al, 2007; Ali et al, 2010; Mangtani et al, 2010;
Maringe et al, 2013). Incidence from the common cancers such as
breast, prostate, lung and colorectal are generally lower in South
Asians, though the rates are steadily converging (Winter et al,
1999; Smith et al, 2003; Maringe et al, 2013).
Previous national and regional studies of breast cancer survival
have shown higher survival for South Asians compared with the
non-South Asian population, even though they tend to live in
poorer areas (dos Santos Silva et al, 2003; Farooq and Coleman,
2005; Jack et al, 2009). Survival from oral (Warnakulasuriya et al,
1999; Moles et al, 2007) and cervical cancers (Bates et al, 2008) was
higher among South Asian migrants compared with non-South
Asians. By contrast, a regional study of cancer survival in children
and young adults under 30 years of age showed that differences
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between South Asians and non-South Asians vary with the type of
tumour: South Asians had poorer survival from leukaemia and
lymphoma compared with non-South Asians, but better outcomes
from solid tumours (van Laar et al, 2012).
We sought to determine how cancer survival in the South Asian
population of England has changed between 1986 and 2004, how it
varies by age and deprivation, and how these patterns compare with
those observed in non-South Asians. We used national cancer
registry data, focusing on the five most common cancers in South
Asians in the period 2000–2004 (Maringe et al, 2013): prostate, lung,
colorectal, non-Hodgkin lymphoma (NHL) and liver in men, and
breast, uterus, ovary, colorectal and NHL in women (index cancer).
Deaths in older South Asians are not always well captured, possibly
due to more frequent travel to South Asia once retired, which could
compromise the estimation of the survival. We therefore limited the
analysis to patients aged 15–69 years at diagnosis.
MATERIALS AND METHODS
Information on ethnic origin in the national cancer registry and
population data were incomplete. Therefore, we applied the
validated SANGRA (South Asian Names and Group Recognition
Algorithm) algorithm (Maringe et al, 2013), after ethical and
statutory approvals, to flag all South Asian patients in the national
cancer registry, making use of their distinctive names. Despite
already high sensitivity and specificity (Nanchahal et al, 2001)
against self-assigned ethnicity (considered as the gold standard),
we also visually inspected all names selected as South Asians to
increase the specificity of the algorithm (Mangtani et al, 2010).
A total of 1 050 644 people were diagnosed in England between
ages 15 and 69 years with an invasive, primary malignancy of
interest. They were registered in the national cancer registry and
followed up for their vital status until 31 December 2007.
The quality of the data were assessed using standard criteria
(Li et al, 2014), leaving 997 104 patients (94.9%) for analysis, among
whom 13 979 (1.4%) were South Asians (Table 1). Proportions of
exclusion varied widely across cancers and between ethnicities:
overall 9.1% in South Asians and 5.0% in non-South Asians, but
reaching 11.2%, 14.5% and 21.9% for NHL, lung and liver cancers in
South Asians, respectively, that is, around 5–6% higher than in non-
South Asians. South Asians were more likely than non-South Asians
to be excluded because of unknown vital status (5.3% vs 0.9%), but
the proportion of death-certificate-only registrations was generally
similar or slightly higher among non-South Asians. Patients with no
information on the postcode of residence at the time of diagnosis
could not be assigned to an ecological deprivation score so they were
also excluded (3058, 0.15%, similar for both ethnic groups).
Net survival, the metric of interest, is the survival that the cancer
patients would experience after adjustment for death from other
causes. Net survival is the only measure enabling comparison of
cancer survival between populations experiencing different levels of
mortality from other causes, as seen between South Asians and
non-South Asians (e.g., for cardiovascular disease). In the absence
of reliable information on the cause of death, net survival is
estimated by comparing the overall mortality of the cancer patients
with the mortality that would have been expected if they did not
have cancer (‘expected’ or ‘background’ mortality), using a non-
parametric estimator (Pohar Perme et al, 2012).
Expected mortality was derived from population life tables that
we constructed by single year of age (0–99 years) and single calendar
year (1986–2004), sex and deprivation category, for the entire
population of England, as well as separately for the South Asian
population. Ethnicity is not recorded at death, and death rates for
South Asians were constructed by assigning ethnicity from the name
in the national mortality database in the Office for National Statistics
(Mangtani et al, 2010), in the same way as for the cases in the
national cancer registry. The number of deaths was taken as the
mean annual number of deaths in the 3 years centred on the census
year, to reduce the effect of random fluctuation. Populations were
taken from the censuses for 1991 and 2001. Each small area was
mapped to a deprivation index: the Carstairs index in 1991
(Carstairs, 1995) and the income domain of the Indices of Multiple
Deprivation (IMD 2004) in 2001 (Department of the Environment
Transport and the Regions, 2000), and aggregated into five
categories by quintile of the national distribution. All-cause death
rates per 100 000 per year by deprivation were then derived after
aggregation of the number of deaths (numerator) and the
population (denominator) by age, sex and ethnic group for each
small area in England (Enumeration District in 1991, Lower Super
Output Area in 2001) into the five deprivation categories. Linear
interpolation was used to obtain a life table for each calendar year
between 1991 and 2001. The 2001 life tables for South Asians and
non-South Asians were assumed to apply over the years 2002–2004,
and the 1991 life tables over the years 1986–1990. This enabled us to
build a complete series of deprivation-specific life tables for South
Asians and non-South Asians over the period 1986–2004. To our
knowledge this is the first time that life tables specific for the South
Asian population have been constructed in the UK (Cancer
Research UK Cancer Survival Group, 2004).
For each cancer, we estimated net survival up to 5 years by
ethnic group, age group and period of diagnosis (1986–1995,
1996–2004) using the Pohar Perme estimator (Pohar Perme et al, 2012)
implemented in the STATA (StataCorp, 2013) command stns
(Clerc-Urme`s et al, 2014). Overall survival estimates were age
standardised using the International Cancer Survival Standard
weights (Corazziari et al, 2004).
Modelling the excess hazard of death enables investigating
further the differences in net survival between South Asians and
non-South Asians, and in particular, whether the effect of ethnicity
varied with time since diagnosis, year of diagnosis, age at diagnosis
and deprivation. The excess hazard of death (or excess mortality)
is a measure of the mortality due to cancer over and above the
expected mortality, defined earlier. In contrast with survival, a
cumulative measure, the hazard is an instantaneous measure and
therefore detects any changes in the rate at which excess or cancer-
related deaths occur. We modelled the excess mortality on the
log-cumulative excess hazard scale, using flexible functions (Nelson
et al, 2007; Lambert and Royston, 2009). We allowed for non-linear
effects of age and year of diagnosis by constructing restricted cubic
splines for these variables, with knots located at the tertiles of the
distributions. We also tested and allowed for time-dependent effects
of ethnicity and other covariates. We used the log-likelihood ratio
test to compare models with and without interactions between all
co-variables and ethnicity, and with and without time-dependent
effects of the interactions. All analyses were conducted using the
stpm2 command (Lambert and Royston, 2009) in STATA 13.
RESULTS
Patterns and trends in cancer survival. Age-standardised net
survival was on average higher in South Asians than in non-South
Asians, for most cancers. That contrast was stronger in 1986–1995
(Table 2). Survival was only lower in South Asians compared with
non-South Asians for uterine cancer and NHL in 1986–1995. In
1996–2004, the survival advantage in South Asians was no longer
seen for breast and prostate cancers especially at 5 years after
diagnosis. The South Asian advantage in survival also considerably
reduced between both periods for the other cancers. By 2004,
survival was higher in South Asians compared with non-South
Asians only for cancers of the colorectum (men), liver and lung.
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For example, in 1996–2004, 5-year colorectal cancer survival in
men was 58.9% (95% CI 55.0–62.8) in South Asians and 53.6%
(53.1–54.1) in non-South Asians. By contrast, 1-year survival from
NHL in women was 73.7% (68.0–79.3) in South Asians and 80.5%
(79.8–81.1) in non-South Asians in 1996–2004; this ethnic
difference in survival has reduced over time.
The reduction in the gap in survival between South Asians and
non-South Asians is a result of survival in non-South Asians
increasing more rapidly than among South Asians between the
early and late 1990s. This general pattern was not observed for the
ovarian and uterine cancer; neither was it seen for NHL for which
survival improved more rapidly among South Asians.
Only lung cancer patients aged 45–54 and 55–64 years at
diagnosis, and NHL patients aged 65–69 years showed evidence of
differences in survival between ethnic groups in the period
1996–2004 (Supplementary Table 1).
In 1986–1995, net survival from lung cancer in South Asian
men was as high as 40.9% and 26.0% at 1 and 5 years, respectively,
compared with only 26.3% and 8.5% in non-South Asians. In
1996–2004, 1- and 5-year survival in South Asians apparently
declined by 6% and 10%, respectively, to reach 35.2% at 1 year and
15.9% at 5 years. By contrast, lung cancer survival among non-
South Asians rose slightly, but was still lower than in South Asians
(Table 2).
A very steep increase was observed in 5-year survival from
prostate cancer in both ethnic groups: 20% in South Asians
between 58.4% (43.3–73.5) and 78.4% (70.1–86.6) and a staggering
30% in non-South Asians between 51.0% (49.4–52.7) and 81.1%
(80.1–82.2).
Patterns of changes in excess mortality. The excess hazard of
death varied between ethnic groups for all cancers except ovarian
and uterine cancers (P-values 0.13 and 0.15, respectively;
Supplementary Table 2). We then tested whether the effect of
ethnicity on the excess hazard changed with time since diagnosis,
year and age of diagnosis and deprivation (Supplementary Table 2).
Excess cancer mortality among South Asians. South Asians
experienced the usual patterns of high excess hazard in the first few
months after diagnosis, followed by excess hazard close to zero at
around 5 years after diagnosis (Figure 1). The excess hazard varied
widely by age, and to a lesser extent by deprivation, in South
Asians diagnosed with NHL, lung, liver and ovarian cancers.
Excess hazard of dying in patients aged 65 years remained higher
than patients aged 50 years until 5 years after diagnosis.
South Asians often experienced lower excess hazard of death
than non-South Asians (lower part of Figure 1) in the 5 years that
followed the cancer diagnosis. For cancers of the colorectum
(women), lung (men) and prostate, South Asians had lower hazard
of death from cancer throughout the first 5 years after diagnosis.
That advantage in excess mortality widened with time since
diagnosis for lung cancer, from a 15% lower mortality shortly after
the diagnosis up to 75% at 5 years. On the other hand, in men, the
excess hazard of death for colorectal and liver cancer became lower
in South Asians only at least after 6 months since diagnosis, leading
Table 1. Number of patients eligible and included for analysis, and percentage excluded, for South Asian and non-South Asian
adults (15–69 years at diagnosis) diagnosed in 1986–2004 and followed up to 2007
Patients excluded (%) Patients included
ICD-10 code Eligible patients Vital status unknown DCOa Other No %
Colorectal C18–C20, C21.8
Non-South Asians 200 628 0.90 3.35 0.59 190918 95.16
South Asians 2078 4.81 3.03 0.58 1903 91.58
Liver (men) C22
Non-South Asians 8141 1.66 14.00 0.09 6859 84.25
South Asians 667 7.05 14.84 — 521 78.11
Lung (men) C33, C34
Non-South Asians 172 322 1.23 7.62 0.57 156094 90.57
South Asians 1797 6.51 7.62 0.39 1536 85.48
Breast (women) C50
Non-South Asians 367 116 0.81 1.35 1.56 353456 96.28
South Asians 5944 4.98 1.28 0.92 5 517 92.82
Ovary C56, C57.0–C57.7
Non-South Asians 59 395 0.90 4.06 0.44 56 190 94.60
South Asians 911 4.94 3.29 0.44 832 91.33
Uterus C54, C55
Non-South Asians 47 590 0.74 1.22 0.37 46 479 97.67
South Asians 776 2.96 0.90 0.13 745 96.01
Prostate C61
Non-South Asians 111 760 0.70 1.72 0.52 108476 97.06
South Asians 1459 4.66 1.51 0.41 1363 93.42
Non-Hodgkin
lymphoma
C26.1, C76.3, C79.8,
C82–C85, C92.9,
C96
Non-South Asians 68 317 1.11 3.74 0.47 64 653 93.83
South Asians 1743 6.37 3.75 0.17 1562 88.80
Total
Non-South Asians 1 035 269 0.91 3.23 0.89 983125 94.96
South Asians 15 375 5.26 3.25 0.57 13 979 90.92
All patients 1 050 644 997104 94.90
aDCO¼death certificate only, these were case identified by death certificate or by autopsy only.
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to 50% and 75% reduction at 5 years, respectively. For ovarian
cancer, lower excess mortality was seen in South Asians only until
6 months after diagnosis.
By contrast, South Asians experienced a higher excess mortality
than non-South Asians for NHL (EHR from 1.23 (1.07–1.42) and
1.39 (1.14–1.71) for men and women, respectively) and for cancers
of the breast (EHR: 1.06 (1.00–1.12)) and the uterus (EHR: 1.14
(0.96–1.34)). This deficit in NHL survival vanished after 18 or 36
months since diagnosis for men and women, respectively.
Temporal trend in excess hazard of death by ethnicity. Among
the few cancers for which the effect of ethnicity seemed to vary
with year of diagnosis (Supplementary Table 2), 3-month and
1-year excess mortality from colorectum and liver cancer decreased
rapidly in non-South Asians between 1986 and 2004, whereas it
remained constant in South Asians, resulting in a reduced or null
gap in excess mortality between both ethnic groups (Figure 2).
Trends in 5-year excess mortality were less clear. For lung cancer
(men), the trends in excess mortality at 3 months and 1 year
diverged between ethnic groups, with a patent increase in South
Asians and a slight decrease in non-South Asians: in 2004, excess
hazards in non-South Asians were at 0.98 (0.96–1.00) and 0.67
(0.66–0.69) at 3 months and 1 year after diagnosis, respectively,
similar to the excess hazards in South Asians (0.94 (0.84–1.05) and
0.55 (0.50–0.62) at 3 months and 1 year). The excess hazards for
prostate cancer decreased much more quickly in non-South Asians
than South Asians, at all times after diagnosis.
Age pattern in excess hazard of death by ethnicity. Excess
mortality by ethnicity varied differently according to age at
diagnosis for colorectal (women), NHL (men) and uterine cancer
patients (Figure 3 and Supplementary Table 2). In South Asians,
patients aged 15–35 years at diagnosis tended to die more from
their colorectal cancer than the patients aged 50–69 years, while in
non-South Asians, the age pattern was reversed, regardless of time
since diagnosis. For the uterine cancer, a general U-shape of the
excess mortality was observed for both ethnicities, but mirrored
with the highest mortality among the younger patients for the
non-South Asians and among the older patients for the South
Asians: at 3 months after diagnosis, the excess hazards were 0.15
(95% CI 0.11–0.21) in South Asians aged 15 years and 0.17
(95% CI 0.13–0.23) in non-South Asians aged 69 years. For NHL
male cancer patients, the increasing excess mortality with
increasing age was much more marked in South Asians than
among non-South Asians, especially 3 months after diagnosis.
Deprivation pattern in excess hazard of death by ethnicity.
Deprivation patterns in South Asians were similar to that in non-
South Asians for most cancers (Supplementary Table 2) with
greater excess mortality in more deprived population. The trends
in breast cancer excess mortality by deprivation was slightly steeper
in South Asians than non-South Asians, while, for prostate cancer,
the high excess mortality observed in non-South Asians shortly
after the diagnosis was attenuated in South Asians for all
deprivation categories (Figure 4). NHL cancer showed very
Table 2. Age-standardised 1- and 5- year net survival (%), by cancer, sex and period of diagnosis for South Asians and non-South
Asians
1986–1995 1996–2004
South Asians Non-South Asians South Asians Non-South Asians
Year No Survival 95% CI No Survival 95% CI No Survival 95% CI No Survival 95% CI
Colorectal
Men 1 421 72.8 68.3 77.4 54 324 72.0 71.6 72.4 795 78.6 75.6 81.5 56 562 78.5 78.1 78.8
5 54.7 49.3 60.1 43.5 43.0 44.0 58.9 55.0 62.8 53.6 53.1 54.1
Women 1 232 80.2 74.3 86.0 40 805 73.8 73.3 74.2 451 80.1 76.1 84.1 38 675 79.9 79.5 80.3
5 57.7 50.1 65.2 46.7 46.2 47.3 61.7 56.6 66.9 57.0 56.4 57.5
Liver
Men 1 162 23.3 16.6 30.0 2609 16.9 15.4 18.4 359 27.3 22.6 32.1 4222 26.4 25.0 27.7
5 15.0 8.8 21.1 4.5 3.6 5.5 15.0 11.0 19.0 9.4 8.4 10.4
Lung
Men 1 694 40.9 37.0 44.8 90 932 26.3 25.9 26.6 837 35.2 31.8 38.6 64 503 29.8 29.4 30.2
5 26.0 22.3 29.7 8.5 8.3 8.7 15.9 13.1 18.6 9.3 9.0 9.5
Breast
Women 1 1885 93.4 91.5 95.3 164 507 93.2 93.1 93.3 3625 96.4 95.5 97.2 187 879 96.2 96.1 96.3
5 74.7 71.3 78.2 74.5 74.2 74.7 82.6 80.8 84.5 84.4 84.1 84.6
Ovary
Women 1 280 71.2 63.5 79.0 27 495 66.2 65.6 66.8 548 80.2 75.9 84.5 28 495 75.9 75.4 76.5
5 35.7 25.9 45.6 34.6 33.9 35.2 48.2 42.6 53.7 44.0 43.3 44.7
Uterus
Women 1 227 91.1 86.9 95.4 21 928 90.1 89.7 90.5 518 92.2 89.7 94.6 24 405 92.3 92.0 92.7
5 71.6 63.2 80.1 78.3 77.7 78.9 78.0 73.7 82.3 81.3 80.7 81.9
Prostate
Men 1 310 a92.3 a88.9 a95.7 35 550 84.4 83.2 85.6 1052 95.2 92.1 98.4 72 724 95.0 94.4 95.5
5 58.4 43.3 73.5 51.0 49.4 52.7 78.4 70.1 86.6 81.1 80.1 82.2
NHL
Men 1 373 66.0 59.7 72.3 17 072 71.8 71.1 72.6 638 70.6 66.1 75.1 19 816 75.9 75.2 76.5
5 48.4 41.3 55.5 50.3 49.4 51.2 57.2 51.9 62.5 57.8 57.0 58.6
Women 1 177 66.7 56.6 76.9 12 538 76.2 75.4 77.0 371 73.7 68.0 79.3 15 051 80.5 79.8 81.1
5 48.5 37.7 59.3 56.5 55.5 57.4 63.3 56.9 69.7 64.9 64.0 65.7
Abbreviations: CI¼ confidence interval; NHL¼ non-Hodgkin lymphoma.
aFor prostate cancer, it is not possible to compute the age-standardised 1-year survival for South Asians in the first period due to small number of patients in the youngest age group.
Unstandardised survival figures are reported instead.
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Figure 1. Excess hazard of death by age and deprivation in South Asians for patients diagnosed in 2004, and excess hazard ratios comparing
South Asians to non-South Asians.
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unstable excess hazard estimates by deprivation for South Asians,
leading to a triangular relationship between excess mortality and
deprivation: most probably, it was the reason for an interaction
between ethnicity and deprivation.
DISCUSSION
This study aims at measuring trends in survival for the five most
common cancers in each sex in South Asians living in England.
To our knowledge, this is the first time survival from cancers other
than breast cancer has been estimated for this ethnic group for the
whole of England and over such a long period of time.
In the late 1980s, net survival in South Asians was either higher
(colorectum, liver, lung and prostate) or similar to that in
non-South Asians (breast, ovary, uterus and NHL). By 2004,
however, the picture was very different: South Asians still
experienced higher survival for lung cancer, but lower survival
for NHL, while survival from other cancers had become similar in
both ethnic groups. Adjusting for age at diagnosis and deprivation
only resulted in small and inconsistent effects on the overall ethnic
differences in survival.
We restricted our analysis to adults aged 15–69 years in order to
avoid potential bias in the estimation of cancer incidence and survival
among elderly South Asians. South Asians also tend to be diagnosed
at younger ages than non-South Asians (Downing et al, 2011;
Maringe et al, 2013).
The literature reports a mixed role for ethnicity and socio-
economic background in cancer survival (Parikh-Patel et al, 2006;
Moles et al, 2007, Jack et al, 2009, National Cancer Intelligence
Network, 2009, van Laar et al, 2012, Ortiz-Ortiz et al, 2014).
Ethnic differences in 1- and 3-year age-standardised survival for
cancers of the colorectum, breast (women) and prostate were
reported to be minor, using HES-derived ethnicity (National
Cancer Intelligence Network, 2009). It was also reported (National
Cancer Intelligence Network, 2009), as we do here, higher lung
cancer survival for Asian patients diagnosed between
2002 and 2006. Our study, however, presents methodological
differences. To estimate the net survival for each ethnic group, we
constructed separate life tables of background mortality for South
Asians by single year of age, sex, deprivation category and calendar
year (Cancer Research UK Cancer Survival Group, 2004; available
on our website at publication). The survival models we employed
included age at diagnosis, year of diagnosis and deprivation status.
This approach provides the tightest possible control for differences
and trends in background mortality by ethnicity and deprivation.
Name recognition remains the best way to identify persons of
South Asian ethnicity when studying trends in population-based
cancer survival in England, because self-assigned ethnicity is not
routinely recorded at registration. Moreover, because some non-
South Asian Muslim names could be confounded with common
South Asian names, we have proceeded to additional checks of
the South Asian names selected by the algorithm among cancer
patients. The use of a name-recognition algorithm on cancer
incidence data permits the inclusion of second and subsequent
generations of migrants in the analyses, unlike using the country of
birth as a proxy for ethnicity. Self-assignment of ethnicity, seen as
the gold standard, is still incomplete in most health data sets
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Figure 2. Change in excess hazard with year of diagnosis, by ethnic group at 3, 12 and 60 months after diagnosis, for cancers selected based on
the significance of the interaction term year of diagnosisethnicity (patients aged 50, most affluent).
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Figure 3. Change in excess hazard with age at diagnosis, by ethnic group at 3, 12 and 60 months after diagnosis, for cancers selected based on
the significance of the interaction term age at diagnosisethnicity (2004, most affluent).
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(such as HES), which contain many records with two or more
conflicting entries for the same patients. It has been advocated that
despite their drawbacks, such data should be analysed anyway in
order to drive up their quality (Aspinall and Jacobson, 2007).
One study of the impact of self-assigned ethnicity on breast cancer
outcomes in South Asians in the UK concluded that any technique
(including imputation of missing ethnicity) used to identify the
‘best’ ethnicity led to very similar results (Downing et al, 2011).
Differences in cancer incidence and survival between Blacks and
Whites (Bassett and Kreiger, 1986; Lannin et al, 1998; Breen et al, 1999)
or within the Asian ethnic group (Pineda et al, 2001; Robbins et al, 2007,
Bates et al, 2008; Gomez et al, 2010) have been reported in the US for
decades, where ethnicity is sometimes used as a proxy for wealth
(Ash and Robinson, 2009). In the US, where the South Asian population
also comprises Japanese and Filipinos, their breast and prostate cancer
survival is lower than in non-Hispanic whites (Robbins et al, 2007).
The hypothesis claiming that the ethnicity gap in survival
widens with increasing amenability of cancer to treatment
(expressed by increasing net survival) was tested in the US using
SEER population-based data in the late nineties (Tehranifar et al,
2009). By amenability to treatment, we mean easy access to
efficient treatment. Compared with the White population, the
survival advantage initially found in Asian and Pacific Islanders
(including South Asians) tended to disappear with increasing
amenability, while deficit in survival observed in all other ethnic
groups widened. Similarly, we found no significant difference
between the survival experienced by South Asians and non-South
Asians, during 1996–2004, for cancers with good survival and good
amenability to treatment (prostate, uterine and breast cancers,
5-year survival higher than 70%) or for partly amenable cancers
(NHL, ovary and colorectal cancer). The South Asian survival
advantage remained over 5% higher in ‘not amenable’ cancers such
as liver (at 5 years) and lung (at both 1 and 5 years). In the US,
Asian ethnicity was identified as a favourable prognostic factor for
overall survival from non-small cell lung cancer in California, even
after adjustment for smoking status (Ou et al, 2009). We also found
a significant advantage in lung cancer survival for South Asians,
which matches the theory of minorities and amenability of cancers
(Tehranifar et al, 2009). However, caution should be made in
particular in the US where access to healthcare strongly depends
on socioeconomic level (Desai et al, 2010).
Part of the temporal variations and ethnic differential in cancer
survival may be due to data issues. For example, lung cancer survival
in South Asians, very high in 1986–1994, decreased dramatically by
11% at 5 years. In 1986–1995, an extra 8% of South Asians compared
with non-South Asians were excluded from the analysis, while the
difference between both ethnic groups decreased to 3% in 1996–2004
(data available on request). Most of this difference was seen in the
exclusion of cases due to unknown vital status, that is, patients could
not be traced to assess their vital status. This could reflect a migration
effect because of the South Asian patients returning to their home
country to die (Pablos-Mendez, 1994, Scott and Timaeus, 2013).
Restricting the age range to patients diagnosed between 15 and 69
years of age has reduced this effect, although the proportion of
unknown vital status was relatively constant in all age groups
(data not shown). Furthermore, in order to evaluate whether the
proportion of patients wrongly recorded as alive (also called
‘immortals’) at the time of the analysis differed by ethnicity, we
calculated (on the full cohort) the proportions of patients who
appeared to have survived beyond their 105th birthday by ethnicity:
they were fairly similar. We also looked at the long-term survivors for
bad prognosis cancers. For liver cancer, 5.7% of South Asians
survived beyond 10 years (5.4% in ages 15–69) compared with
0.9% (0.7% in ages 15–69) in non-South Asians; for lung cancer,
9% (7.6% in ages 15–69) of South Asians and 1.7% (1.4% in ages
15–69) of non-South Asians. It suggests some differential losses to
follow-up (death) by ethnicity.
During the study period, the widest changes in ethnicity-specific
proportion of patients excluded were for liver, lung, and ovarian
cancers and for NHL, whereas survival in South Asians either became
worse than in non-South Asians (NHL) or dropped dramatically
(lung). Except for liver cancer, the proportions of patients excluded in
the most recent period were not greater than 3% of the cases. It
suggests that the more recent comparisons in cancer survival between
both ethnic groups can be considered as more reliable.
Screening uptake in South Asians was lower than in non-South
Asians in 1996 (Szczepura et al, 2008), which might be reflected in
the slower increase in 5-year survival from breast cancer in South
Asians. Similarly, the situation for prostate cancer may be
comparable with lower use of PSA (Melia et al, 2004). Policy on
implementation of the mass screening programme for colorectal
cancer (introduced since 2006) should account for differential
screening uptake in South Asians. However, it should be noted that
two-thirds of South Asian cancer patients belongs to the two most
deprived groups. As screening uptake decreases with increasing
deprivation, disentangling the role of ethnicity from that of
deprivation remains challenging. Nevertheless, differential trends
in survival between both ethnic groups could be partly due to the
differential access to early diagnosis in the more recent years.
Stage-specific survival was not performed because of lack of good
quality information on tumour stage in the national cancer registry
for the whole study period.
Cancer beliefs and attitudes vary between countries and, within
a country, between ethnic groups (Forbes et al, 2011, 2013). South
Asian women were found to have lower breast cancer awareness
than White women (Forbes et al, 2011), while a qualitative study
concluded that South Asian beliefs hindered their understanding of
and access to breast cancer screening (Karbani et al, 2011).
Younger generations, up to a third of the cancer patients in the
most recent years of our study, may be more aware and receptive to
public health messages but communications targeted to minority
ethnic groups should still be used to reach newer generations and
counteract misplaced beliefs. It is worth noticing that incidence of
cervical cancer, although higher in South Asians than in non-South
Asians, followed a similar downward trend in both ethnic groups
(data not shown). That may reflect comparable trends in
prevalence of risk factors and screening uptake. Two studies
showed a survival advantage of South Asians for breast cancer in
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Figure 4. Change in excess hazard with deprivation, by ethnic group at 3, 12 and 60 months after diagnosis, for cancers selected based on the
significance of the interaction term deprivationethnicity (2004, most affluent).
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the late 1980s and early 1990s (dos Santos Silva et al, 2003; Farooq
and Coleman, 2005). Breast cancer survival in non-South Asians is
now similar to that in South Asians, and encouraging self-
examination and screening among South Asians should be a
priority to maintain high South Asian survival.
Area-based deprivation measures were allocated to each cancer
patient and split into five categories according to the quintiles of
these deprivation measures in the English population. If this
distribution remains fairly uniform in White patients, nearly two-
thirds of the South Asian population and cancer patients fall into
the two most deprived categories (data not shown). The
deprivation gradient in cancer incidence was much less steep in
South Asians than among non-South Asians (Maringe et al, 2013).
By contrast, we found that deprivation gradient in cancer survival
was generally similar in both ethnic groups. Socioeconomic
inequalities in cancer survival did not decline following the
implementation of the NHS Cancer Plan (Rachet et al, 2010), in
particular as a consequence of a more rapid increase in survival
among the more affluent cancer patients. Because of the skewed
distribution towards more deprived categories of the South Asians,
the slower survival increase in this population reported here could
reflect more generally the experience of the most deprived groups
in the population.
The more recent patterns of cancer survival in South Asians look
rather similar to those for non-South Asians in England. The
protective effect of South Asian ethnicity on cancer incidence and
survival seems to have faded. This may be explained by the fact that,
in addition to data quality issues, both the first and subsequent
generations age and become more westernised. Majority of South
Asian population, however, lives in most deprived areas while, in
England, poorer cancer survival is largely driven by deprivation
(Rachet et al, 2010). Deprivation is also associated with low
screening uptake (von Wagner et al, 2009) and sub-optimal cancer
management (Morris et al, 2008; Lejeune et al, 2010; Rachet et al,
2010). South Asians show slow increase in breast and prostate
cancer survival; both cancers are associated with either a screening
programme or a test for early stage disease. Without appropriate
action, at least on deprivation-related factors, deficits in cancer
survival may appear among South Asians in the near future.
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